{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05859724",
            "orgStudyIdInfo": {
                "id": "NB-NM026-2198-101"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-503577-38",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Numab Therapeutics AG",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)",
            "officialTitle": "A Randomized, Double-blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Exploratory Clinical Activity of NM26-2198 in Healthy Volunteers and in Adult Patients With Atopic Dermatitis",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "evaluation-of-in-healthy-subjects-and-in-patients-with-moderate-to-severe-atopic-dermatitis-ad"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-02-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-04-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-05",
            "studyFirstSubmitQcDate": "2023-05-05",
            "studyFirstPostDateStruct": {
                "date": "2023-05-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Numab Therapeutics AG",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Kaken Pharmaceutical Co., Ltd.",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a randomized, double-blind, placebo-controlled, single- and multiple ascending dose study of subcutaneous (SC) administration of NM26-2198 in healthy volunteers and adult patients with moderate to-severe AD to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single (SAD) and multiple doses (MAD) of NM26-2198."
        },
        "conditionsModule": {
            "conditions": [
                "Atopic Dermatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 140,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo (for NM26-2198) for subcutaneous (SC) injection in healthy volunteers (HVs) on Day 1 (SAD Cohorts) and on Days 1, 8, 15, and 22 (MAD Cohorts)",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                },
                {
                    "label": "NM26-2198",
                    "type": "EXPERIMENTAL",
                    "description": "NM26-2198 10mg, 50mg, 150mg, 300mg, 400mg, 600mg, and 900mg for SC injection in HVs on Day 1 (SAD Part A); NM26-2198 150mg, 300mg, and 600mg for SC injection in patients with AD (MAD Part B); NM26-2198 150mg and 300mg for SC injection in HVs on Days 1, 8, 15, and 22 (MAD Part C)",
                    "interventionNames": [
                        "Biological: NM26-2198"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "NM26-2198",
                    "description": "IL-4R/IL-31 bispecific antibody for subcutaneous administration",
                    "armGroupLabels": [
                        "NM26-2198"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Placebo for NM26-2198",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of participants with Treatment Emergent Adverse Events (TEAEs) [SAD]",
                    "description": "TEAEs defined as AEs and SAEs developing or worsening during treatment period (time from the first dose of study drug up to the end of study visit \\[Day 57 in SAD\\]), and includes findings from vital signs, electrocardiogram (ECG), clinical laboratory tests, physical examinations, and injection site evaluations.",
                    "timeFrame": "First dose through end of study (Day 57)"
                },
                {
                    "measure": "Percentage of participants with Treatment Emergent Adverse Events (TEAEs) [MAD]",
                    "description": "TEAEs defined as AEs and SAEs developing or worsening during treatment period (time from the first dose of study drug up to the end of study visit \\[Day 85 in MAD\\]), and includes findings from vital signs, electrocardiogram (ECG), clinical laboratory tests, physical examinations, and injection site evaluations.",
                    "timeFrame": "First dose through end of study (Day 85)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Pharmacokinetics of NM26-2198: Peak Concentration (Cmax) [SAD]",
                    "description": "Mean maximum concentration of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Peak Concentration (Cmax) [MAD]",
                    "description": "Mean maximum concentration of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Trough Concentration (Ctrough) [MAD]",
                    "description": "Mean trough concentrations of NM26-2198 with multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time of Peak Concentration (Tmax) [SAD]",
                    "description": "Mean time of maximum concentration of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time of Peak Concentration (Tmax) [MAD]",
                    "description": "Mean time of maximum concentration of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Last Area Under the Curve (AUClast) [SAD]",
                    "description": "Mean area under the curve from the time of dosing to the last measurable concentration of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Last Area Under the Curve (AUClast) [MAD]",
                    "description": "Mean area under the curve from the time of dosing to the last measurable concentration of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Area Under the Curve During the Dosing Interval (AUCtau) [SAD]",
                    "description": "Mean area under concentration-time curve over dosing interval of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 7"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Area Under the Curve During the Dosing Interval (AUCtau) [MAD]",
                    "description": "Mean area under concentration-time curve over dosing interval of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 29"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Estimated Total Exposure (AUCinf) [SAD]",
                    "description": "Mean estimated total exposure to NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Estimated Total Exposure (AUCinf) [MAD]",
                    "description": "Mean estimated total exposure to NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time-Averaged Concentration (AUC%extrap) [SAD]",
                    "description": "Mean time-averaged concentration of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time-Averaged Concentration (AUC%extrap) [MAD]",
                    "description": "Mean time-averaged concentration of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time of last quantifiable concentration (tlast) [SAD]",
                    "description": "Mean estimated time to last quantificable concentration of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Time of last quantifiable concentration (tlast) [MAD]",
                    "description": "Mean estimated time to last quantificable concentration of NM26-2198 after multiple dose administration in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Terminal Elimination Rate (\u03bbz) [SAD]",
                    "description": "Mean terminal elimination rate of NM26-2198 after single dose administrations in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Terminal Elimination Rate (\u03bbz) [MAD]",
                    "description": "Mean terminal elimination rate of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Terminal elimination half-life (t1/2) [SAD]",
                    "description": "Mean terminal elimination half-life of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Terminal elimination half-life (t1/2) [MAD]",
                    "description": "Mean terminal elimination half-life of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Total body clearance (CL/F) [SAD]",
                    "description": "Mean total body clearance of NM26-2198 after single dose administration in healthy subjects.",
                    "timeFrame": "Day 1"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Total body clearance (CL/F) [MAD]",
                    "description": "Mean total body clearance of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Day 1 and Day 22"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Apparent volume of distribution (Vz/F) [SAD]",
                    "description": "Mean apparent volume of distribution of NM26-2198 after single dose administrations in healthy subjects.",
                    "timeFrame": "Day 1"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Apparent volume of distribution (Vz/F) [MAD]",
                    "description": "Mean apparent volume of distribution of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Day 1 and Day 22"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Accumulation ratio of last dose Cmax (Racc,cmax) [MAD]",
                    "description": "Mean accumulation ratio of last dose Cmax of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Day 1 through Day 22"
                },
                {
                    "measure": "Pharmacokinetics of NM26-2198: Accumulation ratio of last dose AUCtau (Racc,AUCtau) [MAD]",
                    "description": "Mean accumulation ratio of last dose AUCtau of NM26-2198 after multiple dose administrations in healthy volunteers and in patients with AD.",
                    "timeFrame": "Day 1 through Day 22"
                },
                {
                    "measure": "Percentage of subjects developing treatment-emergent anti-drug antibodies (ADAs) [SAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Percentage of subjects developing treatment-emergent anti-drug antibodies (ADAs) [MAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Percentage of subjects developing treatment-enhanced anti-drug antibodies (ADAs) [SAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Percentage of subjects developing treatment-enhanced anti-drug antibodies (ADAs) [MAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                },
                {
                    "measure": "Mean ADA titers [SAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 57"
                },
                {
                    "measure": "Mean ADA titers [MAD]",
                    "timeFrame": "Pre-dose on Day 1 through Day 85"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. SAD: Non-Asian ethnicity with grandparents and parents of non-Asian descent or Japanese descent having all four Japanese grandparents born in Japan.\n2. SAD and MAD in Healthy Volunteers: Male or female aged 18 to 55 years; MAD: Male or female \u226518 years of age.\n3. ALL COHORTS: Weight of 45 kg to 100 kg and BMI of 18.0 to 30.0 kg/m2.\n4. SAD and MAD in Healthy Volunteers: Non-childbearing, non-breastfeeding females or males willing to use double barrier contraception or abstention from sex and sperm donation during the study; MAD: Males willing to use double barrier contraception or abstention from sex and sperm donation during the study; non-childbearing females or females of childbearing potential using protocol-defined method contraception, and who is not pregnant, lactating, or breastfeeding.\n5. MAD: Diagnosis of chronic AD.\n6. MAD: EASI score \u226516.\n7. MAD: vIGA-AD\u2122 score of \u22653.\n8. MAD: Atopic lesions cover \u226510% of body surface area (BSA).\n9. MAD: PP-NRS score \u22654.\n10. MAD: Daily use of non-prescription emollient.\n\nNote: Other protocol-defined Inclusion criteria apply.\n\nExclusion Criteria:\n\n1. SAD and MAD in Healthy Volunteers: Any clinically-relevant medical history or lab abnormality, including positive test for SARS-CoV-2, Hepatitis B or C, or HIV; MAD: Clinically-significant, abnormal laboratory findings, or positive test for SARS-CoV-2, Hepatitis B or C, or HIV.\n2. ALL COHORTS: Clinically important ECG abnormalities or history/evidence thereof.\n3. SAD and MAD in Healthy Volunteers: Use of prescription or non-prescription medications (except occasional use of paracetamol).\n4. MAD: Diagnosis of protocol-specified skin diseases other than AD, or history of other significant skin condition that could interfere with study assessments.\n5. MAD: History or ongoing allergy/hypersensitivity or history, or history of hypersensitivity to biological drugs.\n6. MAD: Recent receipt of immunoglobulin or blood products.\n7. MAD: Recent treatment with protocol-specified investigational treatments, or any prior treatment with dupilumab, tralokinumab, lebrikizumab, nemolizumab, or other protocol-specified drugs.\n8. MAD: AD with recent ocular involvement requiring chronic ocular corticosteroid treatment.\n9. MAD: Chronic pruritis due to conditions other than AD.\n10. MAD: Acute AD superinfection, recent superficial skin infection, or other chronic/acute infection requiring protocol-defined treatments.\n11. MAD: Recent use of sedating antihistimines, systemic corticosteroids, cytotoxic treatments, other immunosuppressive/immunomodulating agents, and other protocol-specified prohibited medications.\n12. MAD: Recent topical corticosteroid or prescription moisturizer use.\n\nNote: Other protocol-defined Exclusion criteria apply.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Peter Lichtlen, MD, PhD, BBA",
                    "role": "CONTACT",
                    "phone": "+41-44-533-22-92",
                    "email": "clinicaltrials@numab.com"
                }
            ],
            "locations": [
                {
                    "facility": "First OC Dermatology Research",
                    "status": "RECRUITING",
                    "city": "Fountain Valley",
                    "state": "California",
                    "zip": "92708",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.70918,
                        "lon": -117.95367
                    }
                },
                {
                    "facility": "Center for Dermatology Clinical Research",
                    "status": "RECRUITING",
                    "city": "Fremont",
                    "state": "California",
                    "zip": "94538",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.54827,
                        "lon": -121.98857
                    }
                },
                {
                    "facility": "California Clinical Trials Medical Group (CCTMG) managed by Parexel",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "California",
                    "zip": "91206",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Principal investigator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14251,
                        "lon": -118.25508
                    }
                },
                {
                    "facility": "UCLA Department of Medicine",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "TCR Medical Corporation",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Annexus Dermatology & Aesthetics",
                    "status": "RECRUITING",
                    "city": "DeLand",
                    "state": "Florida",
                    "zip": "32720",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.02832,
                        "lon": -81.30312
                    }
                },
                {
                    "facility": "D&H Tamarac Research Center",
                    "status": "RECRUITING",
                    "city": "Tamarac",
                    "state": "Florida",
                    "zip": "33321",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.21286,
                        "lon": -80.24977
                    }
                },
                {
                    "facility": "Sadick Research Group",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10075",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Paddington Testing Co.",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Alberta DermaSurgery Centre",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G1C3",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "University of Alberta Hospital",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G2B7",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "DermEffects",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "Ontario",
                    "zip": "N6H5L5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.98339,
                        "lon": -81.23304
                    }
                },
                {
                    "facility": "Centre de Recherche Saint-Louis",
                    "status": "RECRUITING",
                    "city": "Qu\u00e9bec",
                    "zip": "G1W4R4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Frankfurt am Main - Klinik f\u00fcr Dermatology",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "state": "Hessen",
                    "zip": "60590",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Universit\u00e4tsmedizin Mainz",
                    "status": "RECRUITING",
                    "city": "Mainz",
                    "state": "Hessen",
                    "zip": "55131",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.98419,
                        "lon": 8.2791
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Bonn A\u00f6R",
                    "status": "RECRUITING",
                    "city": "Bonn",
                    "state": "Nordrhein-Westfalen",
                    "zip": "53127",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.73438,
                        "lon": 7.09549
                    }
                },
                {
                    "facility": "Universit\u00e4tsklinikum Carl Gustav Carus",
                    "status": "RECRUITING",
                    "city": "Dresden",
                    "state": "Sachsen",
                    "zip": "01307",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.05089,
                        "lon": 13.73832
                    }
                },
                {
                    "facility": "UK-SH - L\u00fcbeck",
                    "status": "RECRUITING",
                    "city": "L\u00fcbeck",
                    "state": "Schleswig-Holstein",
                    "zip": "23538",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.86893,
                        "lon": 10.68729
                    }
                },
                {
                    "facility": "COPERNICUS Podmiot Leczniczy Sp. z o.o., Szpital Sw. Wojciecha",
                    "status": "RECRUITING",
                    "city": "Gdansk",
                    "zip": "80-462",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 54.35205,
                        "lon": 18.64637
                    }
                },
                {
                    "facility": "Uniwersytecki Szpital Kliniczny im. F.Chopina w Rzeszowie",
                    "status": "RECRUITING",
                    "city": "Rzesz\u00f3w",
                    "zip": "35-055",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.04132,
                        "lon": 21.99901
                    }
                },
                {
                    "facility": "Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02-507",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Klinika Ambroziak Dermatologia",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02-953",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003876",
                    "term": "Dermatitis, Atopic"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000004485",
                    "term": "Eczema"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "asFound": "Atopic Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M20194",
                    "name": "Antibodies, Bispecific",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}